LOS ANGELES, Jan. 9, 2020 /PRNewswire-PRWeb/ -- D'OXYVA® is a validated circulatory and nerve stimulant. The system was used by Prof. Puruhito for COâ‚‚ transdermal delivery, which has been shown to ...
MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (OTCMKTS:GNBT) today announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeutix, Inc. has signed critical ...
Hypertrophic scars remain one of the most persistent challenges in wound healing, often resulting in excessive fibrosis, disfigurement, and long-term functional impairment. Researchers now report a ...
Please provide your email address to receive an email when new articles are posted on . Regenity will cover manufacturing and Avita will lead marketing and distribution. The product generates a dermal ...
Please provide your email address to receive an email when new articles are posted on . In this Healio video exclusive, George Martin, MD, discusses highlights from Maui Derm NP+PA, including a new ...
(Left to Right) Principal Investigator Dr. Johnson V. John and Postdoctoral Researcher Dr. Meenakshi Kamaraj, showcasing the injectable granular filler that provides an innovative approach to diabetic ...
APOSEC is a substance obtained from white blood corpuscles and was developed by a research group led by thoracic surgeon Hendrik Jan Ankersmit, Head of the Christian Doppler Laboratory for Cardiac and ...
Non-healing wounds continue to cause significant patient burden. This article outlines a new 3D wound healing model that is committed to enabling the evolution of novel treatments to encourage wound ...
Abstract: Non-healing skin wounds inflict nearly 5 million Americans each year, and translate into multi-billion dollar healthcare costs. Tissue engineering approaches using cell-based dermal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results